Access cutting-edge liver cancer treatment through this clinical trial at a research site in New Orleans. Study-provided care at no cost to qualified participants.
Access liver cancer specialists in New Orleans at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver cancer treatment provided free
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibod
Sponsor: Academic and Community Cancer Research United
Check if you qualify for this liver cancer clinical trial in New Orleans, LA
If you're searching for liver cancer treatment options in New Orleans, LA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Orleans research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.